Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 3Breast 2

Conditions

Breast Neoplasms 6Overweight 2Obesity 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Sexual Dysfunctions, Psychological 1Ovarian Neoplasms 1Depressive Disorder, Major 1

Interventions

Exercise 8exemestane 3Tamoxifen 3Methods 3Metformin 3Early Intervention, Educational 3Diet Therapy 3Vitamin D 2Sugars 2Specimen Handling 2Naltrexone 2Mammography 2Letrozole 2Diet, Mediterranean 2Counseling 2Cognitive Behavioral Therapy 2Cholecalciferol 2Bupropion 2Blood Specimen Collection 2Bariatric Surgery 2Anastrozole 2rosiglitazone-metformin combination 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Yoga 1Walking 1Tirzepatide 1Tablets 1TOPS 1Soybean Proteins 1Rosiglitazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Obesity × Bupropion × Breast × Clear all
NCT04499950 2025-03-06

A-NEW

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
53 enrolled 14 charts
BreastOther

Breast Neoplasms, Obesity, Overweight

NCT03581630 2018-08-29

Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients

Gangnam Severance Hospital

Phase NA Completed
72 enrolled
BreastOther

Breast Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡